Prospective Cohort Study of Rapid Response Team

June 27, 2021 updated by: Seoul National University Hospital
The purpose of this study is to collect data of rapid response team activated patients prospectively

Study Overview

Detailed Description

acutely deteriorating patients including sudden cardiac arrest in general ward who are monitored and intervened by rapid response team

Study Type

Observational

Enrollment (Anticipated)

79800

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Seongnam-si, Korea, Republic of
        • Recruiting
        • Seoul National University Bundang Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients admitted to general ward in Seoul National University Bundang Hospital and monitored by in-hospital rapid response system.

Description

Inclusion Criteria:

- Patients admitted to general ward in Seoul National University Bundang Hospital and monitored by in-hospital rapid response system.

Exclusion Criteria:

  • patients admitted to pediatric wards
  • patients in emergency room, intensive care unit, and operating room

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
mortality or ICU admission of rapid response team activated patient
Time Frame: an average of 1 year
an average of 1 year
incidence of preventable cardiac arrest
Time Frame: an average of 1 year
an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of triggerring criteria(1) for activation of rapid response team
Time Frame: an average of 1 year
SBP <90mmHg(mABP 60mmHg) +- clinically correlated symptom or sign
an average of 1 year
Frequency of triggerring criteria(2) for activation of rapid response team
Time Frame: an average of 1 year
HR: <50/min or >140/min or symptomatic arrythmia
an average of 1 year
Frequency of triggerring criteria(3) for activation of rapid response team
Time Frame: an average of 1 year
RR: <10/min or >30/min or stridor(sign of airway obstruction) or accessary muscle use
an average of 1 year
Frequency of triggerring criteria(4) for activation of rapid response team
Time Frame: an average of 1 year
Oxygenation: SaO2 <90% in room air or FM 8L/min
an average of 1 year
Frequency of triggerring criteria(5) for activation of rapid response team
Time Frame: an average of 1 year
Metabolic acidosis: Lactic acid<2.5 , TCO2 <15
an average of 1 year
Frequency of triggerring criteria(6) for activation of rapid response team
Time Frame: an average of 1 year
ABGA abnormality : PaCO2>50 or pH<7.3 or PaO2<60
an average of 1 year
Frequency of triggerring criteria(7) for activation of rapid response team
Time Frame: an average of 1 year
ABGA abnormality : PaCO2>50 or pH<7.3 or PaO2<60
an average of 1 year
Frequency of triggerring criteria(8) for activation of rapid response team
Time Frame: an average of 1 year
Any serious concern about overall deterioration detected by doctor, nurse and caregiver at bedside
an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yeon Joo Lee, MD, Seoul National University Bundang Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2016

Primary Completion (Anticipated)

November 1, 2022

Study Completion (Anticipated)

November 1, 2026

Study Registration Dates

First Submitted

November 4, 2016

First Submitted That Met QC Criteria

December 6, 2016

First Posted (Estimate)

December 8, 2016

Study Record Updates

Last Update Posted (Actual)

June 30, 2021

Last Update Submitted That Met QC Criteria

June 27, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SAFER_20161101

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hospital Rapid Response Team

3
Subscribe